Drug makers Aurobindo Pharma, Glenmark and Zydus are recalling products in the US market due to manufacturing issues, according to the US health regulator. As per the latest Enforcement Report of ...
Drug makers Aurobindo Pharma, Glenmark and Zydus are recalling products in the US market due to manufacturing issues, according to the US health regulator. According to the latest Enforcement ...
Drug makers Aurobindo Pharma, Glenmark and Zydus are recalling products in the US market due to manufacturing issues, according to the US health regulator. As per the latest Enforcement Report of ...
27d
Glenmark Pharmaceuticals issued seven recalls for pills that didn’t dissolve properly, records show. All were made at the same factory in India. But the FDA still hasn’t stopped the company from ...
The tablets were shipped out across the U.S., though Aurobindo didn’t specify where the products were manufactured. Glenmark Pharmaceuticals, for its part, issued voluntary recalls for 90,528 ...
we'll be launching 3, 4 new products. And then Q4 onwards, you should see the numbers go up even further," he added. Glenmark's North America business clocked revenue of Rs 740.5 crore for the ...
Glenmark’s current portfolio includes 201 products authorized for distribution in the US marketplace and 51 ANDA’s pending approval with the US FDA. In addition to these internal filings, Glenmark ...
Polyneuropathy Treatment Market Benefiting from Innovations in Neuromodulation Techniques and High Focus on Pain ManagementRockville, MD , Jan. 07, 2025 (GLOBE NEWSWIRE) -- According to Fact.MR, a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback